Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HART: Protamine Dose for Heparin Neutralization
NCT03787641Unknown
- Start
- Sep 2018
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial of protamine in heparin-induced thrombocytopenia (HIT). Primary endpoints: Change in heparin activity and Change in Activated Clotting Time. Status: unknown.
02
Drugs
protamine
03
Conditions
heparin-induced thrombocytopenia (HIT)
Beyond the preview
Go deeper on NCT03787641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03787641.